New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu
Oncology December 25,2023
Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

Extreme phenotype approach identifies rare ATR variants as potential male breast cancer susceptibility alleles

by Impact Journals LLCImpact of splicing variants. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28358In oncogenetics, some patients could be considered as "extreme phenotypes,&qu
Oncology December 25,2023
Timely surveillance with chest imaging may benefit colorectal cancer patients

Timely surveillance with chest imaging may benefit colorectal cancer patients

byAmerican College of SurgeonsEarly chest imaging may benefit colorectal cancer patients. Credit: American College of SurgeonsColorectal cancer patients with certain clinical characteristics may
Oncology December 25,2023
Timely surveillance with chest imaging may benefit colorectal cancer patients

Timely surveillance with chest imaging may benefit colorectal cancer patients

byAmerican College of SurgeonsEarly chest imaging may benefit colorectal cancer patients. Credit: American College of SurgeonsColorectal cancer patients with certain clinical characteristics may
Oncology December 25,2023
Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

byUCLA Engineering Institute for Technology AdvancementVirtual HER2 staining of unlabeled breast tissue sections using deep learning. Credit: Ozcan Lab @ UCLA.Breast cancer is one the leading ca
Oncology December 25,2023
Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

byUCLA Engineering Institute for Technology AdvancementVirtual HER2 staining of unlabeled breast tissue sections using deep learning. Credit: Ozcan Lab @ UCLA.Breast cancer is one the leading ca
Oncology December 25,2023
New method for early detection of multi-cancers based on human metabolism

New method for early detection of multi-cancers based on human metabolism

bySwedish Research CouncilValidation of the pruned combined free GAGome MCED score. (A) Validation study subject flow (see also SI Appendix, Fig. S17). (B) Pruned combined free GAGome MCED score
Oncology December 25,2023
New method for early detection of multi-cancers based on human metabolism

New method for early detection of multi-cancers based on human metabolism

bySwedish Research CouncilValidation of the pruned combined free GAGome MCED score. (A) Validation study subject flow (see also SI Appendix, Fig. S17). (B) Pruned combined free GAGome MCED score
Oncology December 25,2023
Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i
Oncology December 25,2023
Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

Antibody-based therapy eliminates circulating tumor cells in mouse models of breast and pancreatic cancer

by Katie Marquedant,Massachusetts General Hospital(A) Schema for the mouse models of neoadjuvant placebo or 23C6 treatment. (B) Tumor volume measurements of 4T1 orthotopic mammary gland tumors i
Oncology December 25,2023
Benefit of risk-based breast cancer screening is still unclear

Benefit of risk-based breast cancer screening is still unclear

by Austrian Institute for Health Technology Assessment GmbHCredit: Unsplash/CC0 Public DomainThe Austrian Institute for Health Technology Assessment (AIHTA) has analyzed whether risk-based breast canc
Oncology December 25,2023
Benefit of risk-based breast cancer screening is still unclear

Benefit of risk-based breast cancer screening is still unclear

by Austrian Institute for Health Technology Assessment GmbHCredit: Unsplash/CC0 Public DomainThe Austrian Institute for Health Technology Assessment (AIHTA) has analyzed whether risk-based breast canc
Oncology December 25,2023
Genomic testing can identify African American prostate cancer patients who have high-risk disease

Genomic testing can identify African American prostate cancer patients who have high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainAfrican American men tend to be diagnosed more frequently with prostate cancer and have higher mortality
Oncology December 25,2023
Genomic testing can identify African American prostate cancer patients who have high-risk disease

Genomic testing can identify African American prostate cancer patients who have high-risk disease

byH. Lee Moffitt Cancer Center & Research InstituteCredit: Unsplash/CC0 Public DomainAfrican American men tend to be diagnosed more frequently with prostate cancer and have higher mortality
Oncology December 25,2023
How genome doubling helps cancer develop

How genome doubling helps cancer develop

byEcole Polytechnique Federale de LausanneChromosomes in cells with whole genome doubling. Credit: Elisa Oricchio/Giovanni Ciriello (EPFL/UNIL)A single cell contains 2-3 meters of DNA, meaning t
Oncology December 25,2023
How genome doubling helps cancer develop

How genome doubling helps cancer develop

byEcole Polytechnique Federale de LausanneChromosomes in cells with whole genome doubling. Credit: Elisa Oricchio/Giovanni Ciriello (EPFL/UNIL)A single cell contains 2-3 meters of DNA, meaning t
Oncology December 25,2023
Genomic assay may predict long-term prognosis in premenopausal patients with HR-positive early-stage breast cancer

Genomic assay may predict long-term prognosis in premenopausal patients with HR-positive early-stage breast cancer

byAmerican Association for Cancer ResearchThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in
Oncology December 25,2023
Genomic assay may predict long-term prognosis in premenopausal patients with HR-positive early-stage breast cancer

Genomic assay may predict long-term prognosis in premenopausal patients with HR-positive early-stage breast cancer

byAmerican Association for Cancer ResearchThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in
Oncology December 25,2023
How genetics play a role in developing melanoma

How genetics play a role in developing melanoma

byCleveland ClinicCredit: Pixabay/CC0 Public DomainA recent study from Cleveland Clinic shows that melanoma, which is the most serious type of skin cancer, isn't just caused by environmental
Oncology December 25,2023
How genetics play a role in developing melanoma

How genetics play a role in developing melanoma

byCleveland ClinicCredit: Pixabay/CC0 Public DomainA recent study from Cleveland Clinic shows that melanoma, which is the most serious type of skin cancer, isn't just caused by environmental
Oncology December 25,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com